直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 111187
著者
Morimoto, Masami The University of Tokushima
Takahashi, Masako Tokushima Breast Care Clinic
本田, 純子 Higashitokushima National Hospital
吉田, 卓弘 The University of Tokushima KAKEN研究者をさがす
吉田, 光輝 The University of Tokushima KAKEN研究者をさがす
井本, 逸勢 The University of Tokushima KAKEN研究者をさがす
Sasa, Mitsunori Tokushima Breast Care Clinic
キーワード
Breast cancer
post-menopausal women
serum E2
high-sensitivity RIA
LC-MS/MS
資料タイプ
学術雑誌論文
抄録
Background : Serum E2 must be monitored for aromatase inhibitor (AI) therapy, but conventional assays lack sensitivity. Subjects/Methods : Forty amenorrheic breast cancer patients scheduled for AI treatment but requiring hormonological confirmation of their menopausal status were studied. Serum E2 data generated by high-sensitivity RIA and by LC-MS/MS were analyzed for correlation. Results : RIA gave a higher E2 value than LC-MS/MS in 62% of cases, but there was a significant positive correlation. Patients whose E2 levels by RIA were≥2.5 pg/mL higher than those by LC-MS/MS (RIA-H group) and all other patients (RIA-N group) were compared. Both groups showed strong correlations between the two assay methods. With both methods patients with a high BMI had significantly elevated E2. Multiple regression analysis used age, age at menarche, number of births and BMI as explanatory variables. Significant variables were the BMI with LC-MS/MS, and both BMI and age with RIA. The RIA-H and RIA-N groups showed no difference in regard to the BMI, whereas the age was significantly lower in the RIA-H group. Summary : Serum E2 levels determined for postmenopausal women by RIA and LC-MS/MS generally correlated well. High-sensitivity RIA is a potentially useful clinical assay, but it overestimated serum E2 in some women.
掲載誌名
The Journal of Medical Investigation
ISSN
13496867
13431420
cat書誌ID
AA11166929
AA12022913
出版者
Faculty of Medicine Tokushima University
63
3-4
開始ページ
236
終了ページ
240
並び順
236
発行日
2016-08
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
病院
医学系